To Explore the Potential Inhibitors against Multitarget Proteins of COVID 19 using In Silico Study
The global pandemic due to emergence of COVID 19 has created the unrivaled public health crisis. It has huge morbidity rate never comprehended in the recent decades. Researchers have made many efforts to find the optimal solution of this pandemic. Progressively, drug repurposing is an emergent and powerful strategy with saving cost, time, and labor. Lacking of identified repurposed drug candidates against COVID 19 demands more efforts to explore the potential inhibitors for effective cure. In this study, we used the combination of molecular docking and machine learning regression approaches to explore the potential inhibitors for the treatment of COVID 19. We calculated the binding affinities of these drugs to multitarget proteins using molecular docking process. We perform the QSAR modeling by employing various machine learning regression approaches to identify the potential inhibitors against COVID 19. Our findings with best scores of R2 and RMSE demonstrated that our proposed Decision Tree Regression (DTR) model is the most appropriate model to explore the potential inhibitors. We proposed five novel promising inhibitors with their respective Zinc IDs ZINC (3873365, 85432544, 8214470, 85536956, and 261494640) within the range of -19.7 kcal/mol to -12.6 kcal/mol. We further analyzed the physiochemical and pharmacokinetic properties of these most potent inhibitors to examine their behavior. The analysis of these properties is the key factor to promote an effective cure for public health. Our work constructs an efficient structure with which to probe the potential inhibitors against COVID-19, creating the combination of molecular docking with machine learning regression approaches.
Code (0)
등록된 구현이 없습니다.
Tasks
Molecular DockingregressionSimilar Papers 제목 키워드 기반
Searching inhibitors for three important proteins of COVID-19 through molecular docking studies
The lack of recommended drugs or vaccines to deal with the COVID-19 is the main concern of this pandemic. The approved drugs for similar health problems, drugs under clinical trials, and molecules from medicinal plants e…
Molecular DockingIn silico ADMET and molecular docking study on searching potential inhibitors from limonoids and triterpenoids for COVID-19
Virtual screening of phytochemicals was performed through molecular docking, simulation, in silico ADMET and drug-likeness prediction to identify the potential hits that can inhibit the effects of SARS-CoV-2. Considering…
Molecular DockingComputationally repurposed drugs and natural products against RNA dependent RNA polymerase as potential COVID-19 therapies
For fast development of COVID-19, it is only feasible to use drugs (off label use) or approved natural products that are already registered or been assessed for safety in previous human trials. These agents can be quickl…
PaccMann$^{RL}$ on SARS-CoV-2: Designing antiviral candidates with conditional generative models
With the fast development of COVID-19 into a global pandemic, scientists around the globe are desperately searching for effective antiviral therapeutic agents. Bridging systems biology and drug discovery, we propose a de…
Drug DiscoveryPrediction of Potential Commercially Available Inhibitors against SARS-CoV-2 by Multi-Task Deep Learning Model
The outbreak of COVID-19 caused millions of deaths worldwide, and the number of total infections is still rising. It is necessary to identify some potentially effective drugs that can be used to prevent the development o…
Molecular Docking